Détail de l'auteur
Auteur A. RITTER |
Documents disponibles écrits par cet auteur (39)
Ajouter le résultat à votre sélection Affiner la recherche
During the past decade, 'alcohol's harm to others' (AHTO) has emerged as an international approach to studying alcohol problems and informing policy. The AHTO approach seeks to increase political will for alcohol policy by mapping, measuring and[...]NouveautéV. BELACKOVA ; A. RITTER ; M. SHANAHAN ; C. E. HUGHES | 2017
Dans International Journal of Drug Policy (Vol.41, March 2017) Article : PériodiqueBackground: Variations in drug laws, as well as variations in enforcement practice, exist across jurisdictions. This study explored the feasibility of categorising drug laws "on the books" in terms of their punitiveness, and the extent of their [...]FRANÇAIS : La buprénorphine haut dosage (Subutex°) est désormais mise sur le marché australien et agréée comme médication de substitution pour le traitement des dépendances aux opiacés. Les formes galéniques sont les mêmes qu'en France : compr[...]A. RITTER ; M. LIVINGSTON ; J. CHALMERS ; L. BERENDS ; P. REUTER | 2016
Dans International Journal of Drug Policy (Vol.31, May 2016) Article : PériodiqueBackground: A central policy research question concerns the extent to which specific policies produce certain effects - and cross-national (or between state/province) comparisons appear to be an ideal way to answer such a question. This paper ex[...]M. SHANAHAN ; A. RITTER | 2013
Dans Drugs: Education, Prevention and Policy (Vol.20, n°3, June 2013) Article : PériodiqueCost-benefit analysis (CBA), with its foundation in social welfare theory, is widely used to assess programs in a range of policy areas. Many CBAs are conducted by simply quantifying the implementation costs and valuing one or more of the potent[...]AIMS: To date there has been limited analysis of the economic costs and benefits associated with cannabis legalisation. This study redresses this gap. A cost benefit analysis of two cannabis policy options the status quo (where cannabis use is i[...]C. WILKINS, Auteur ; A. RITTER, Auteur du commentaire ; L. VON DIEMEN, Auteur du commentaire ; S. ROLLES, Auteur du commentaire ; D. KUSHLICK, Auteur du commentaire ; A. L. BRETTEVILLE-JENSEN, Auteur du commentaire ; B. HUGHES, Auteur du commentaire ; P. GRIFFITHS, Auteur du commentaire | 2014
Dans Addiction (Vol.109, n°10, October 2014) Article : PériodiqueBackground: New Zealand has recently attempted to address the underlying drivers of the escalating new psychoactive substances (NPS) ('legal highs') problem by establishing the world's first pre-market approval regulatory regime for NPS. NPS pro[...]K. O'REILLY ; M. KOWALSKI ; M. J. BARRATT ; A. RITTER | 2022
Dans International Journal of Drug Policy (Vol.103, May 2022) Article : PériodiqueThe ability to fairly and justly distinguish between drug possession for personal use and drug possession for supply is a central feature of drug laws across the globe. Whether such distinctions pertain to decriminalisation of simple possession,[...]V. BELACKOVA ; A. M. SALMON ; C. A. DAY ; A. RITTER ; M. SHANAHAN ; D. HEDRICH ; T. KERR ; M. JAUNCEY | 2019
Dans Drug and Alcohol Review (Vol.38, n°4, May 2019) Article : PériodiqueISSUES: Drug consumptions rooms (DCR) and supervised injecting facilities (SIF) are expanding internationally. Previous reviews have not systematically addressed evaluation methodologies. APPROACH: Results from systematic searches of scientific [...]C. E. HUGHES ; A. RITTER ; N. MABBITT | 2013
Dans International Journal of Drug Policy (Vol.24, n°3, May 2013) Article : PériodiqueBackground: Coordination has been recognised as a critical ingredient for successful drug policy governance. Yet what coordination means and how we assess the processes, outputs and outcomes of drug policy coordination is seldom defined. In this[...]M. HAMILTON ; T. KING ; A. RITTER ; S. ALBERTI ; L. BERENDS ; Y. BONOMO ; CVETKOVSKI S. ; P. DIETZE ; DONATH S. ; GARDINER P. ; M. KEENAN ; KELLEHEAR A. ; KUTIN J. J. ; E. LANG ; LASLETT A. M. ; N. LEE ; N. LINTZERIS ; OTMAR R. ; M. PATTERSON ; RUMBOLD G. ; P. SPRY-BAILEY ; G. WHELAN | 2004
LivreENGLISH : Drug Use in Australia describes policy, prevention and treatment responses to drug use, and details the social and political implications of these approaches. Key sociological, historical and psychological theories are described, wit[...]A. RITTER ; G. BAMMER ; M. HAMILTON ; L. MAZEROLLE ; DPMP Team | 2007
Dans Drug and Alcohol Review (Vol.26 n°3, 2007) Article : PériodiqueENGLISH : The aim of this paper is to describe a new comprehensive approach to studying illicit drug policy - one that integrates evidence, disciplinary approaches, drug use behaviours and policy making processes. The methods described here in[...]K. LANCASTER ; R. SUTHERLAND ; A. RITTER | 2014
Dans Drugs: Education, Prevention and Policy (Vol.21, n°2, April 2014) Article : PériodiqueAims: This study aimed to investigate whether there is heterogeneity of opinion about drug policies amongst people with different experiences of drug use, so as to stimulate discussion about how the diverse perspectives of people who use drugs c[...]ENGLISH : Aims: To determine the role of treatment and client characteristics associated with the achievement of continuous heroin abstinence. Design: Longitudinal cohort study. Setting: Sydney and Adelaide, Australia. Participants: 570 heroin[...]S. R. FRIEDMAN, Auteur ; P. MATEU-GELABERT, Auteur ; D. ROSSI, Auteur ; A. RITTER, Auteur du commentaire ; A. FORDHAM, Auteur du commentaire ; R. CURTIS, Auteur du commentaire ; K. DOMBROWSKI, Auteur du commentaire | 2012
Dans Substance Use and Misuse (Vol.47, n°13-14, 2012) Article : PériodiqueDiscussions of drug policy tend not to consider whether the stated goals of policies are an accurate statement of what they are meant to do and also may not consider the fact that what benefits some people may harm others. We explore these issue[...]